Biomarkers for the early diagnosis of sepsis in burns: systematic review and meta-analysis
Li AT, Moussa A, Gus E et al. Ann Surg 2022;275(4):654–662
Li AT, Moussa A, Gus E et al. Ann Surg 2022;275(4):654–662
We are probably all familiar with the problems of information storage and retrieval, where transition to newer systems, platforms, databases, etc, can mean that information previously stored can no longer be accessed easily, if at all. This article discusses how a system of digital methodology has been developed that gives immediate visibility and clinical utility […]
Approaches, significance and challenges Cell proliferation is a hallmark of cancer associated with aggressiveness and response to chemotherapy. In breast cancer (BC), assessment of proliferation constitutes the main component of grading and help in management. Herein, we address the most common approaches for BC proliferation assessment, their limitations, and evolving applications to overcome these challenges.
The in situ stage of conjunctival squamous cell carcinoma is called conjunctival squamous intraepithelial neoplasia (CSIN). The use of terms such as Bowen’s disease and ocular surface squamous neoplasia are discouraged as their meanings vary and are prone to misinterpretation. The severity of squamous epithelial dysplasia is graded by the proportion of involved surface epithelium. […]
The recent COVID-19 pandemic and race to develop vaccines against the causative agent, severe acute respiratory syndrome coronavirus 2, has reminded us of the important role that protein glycosylation plays in the mechanisms of pathogen infection and host immune response. CLI caught up with Dr Sanda and Dr Campos (both at Team Scientific Service Group […]
The impact of the microbiome on a person’s health and disease is only slowly being fully realized. Here Bio-Me introduce themselves and their work to factor in the microbiome to the delivery of precision medicine.
Secretoneurin is a small neuropeptide detectable in the blood and is strong predictor for mortality in several patient cohorts with underlying cardiovascular disease. Here, CardiNor introduce themselves and their work to develop a secretoneurin test to use as part of a biomarker panel for cardiovascular disease.
Scientific and technical advances in the field of Microchip Imaging Cytometry (MIC) are set to advance quantitative diagnostic testing that may deliver more economical, easy-to-use, and accessible healthcare to the public, according to a new article published in Opto-Electronic Advances [1].
As the cannabis derivative delta-8-THC grows in popularity, it’s important for drug tests to be able to detect and differentiate it from delta-9-THC – the primary psychoactive ingredient in cannabis. Breaking research showcased at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo demonstrates that common drug testing methods can do just that.
A first-of-its-kind test could make it easier for newborns to get care for spinal muscular atrophy, a common genetic disease that is life-threatening but treatable if caught in time. Findings on this method and a second innovative test that could improve diagnosis of paediatric urinary tract infections (UTIs) were discussed at the 2022 AACC Annual […]
November 2024
The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy